2018-2019 Seminar Series

Seminars are held on Wednesdays at 3:30 p.m. in Rayford Auditorium (Biomed II, Room 106-2).

October 10, 2018
Melissa Clemens, MPH (Graduate Student, UAMS)
“Phosphatidic Acid in Liver Regeneration after Acetaminophen Overdose: Significance and Signaling Mechanisms”

October 31, 2018
Lauren Russell, B.S. (Graduate Student, UAMS)
“Structure-Activity Relationships of Substituted Amphetamines and Cathinones in Mice”

November 7, 2018
Li Pang, M.D., Staff Fellow, National Center for Toxicological Research
Evaluation of Drug-Induced Cardiotoxicity with Human iPSC-CMs

November 14, 2018
Brent Hill, Ph.D., Professor & Chair, Department of Biology, University of Central Arkansas
The Effect of Space Travel: The Path Toward Understanding the Effect of Microgravity on the Vascular & Skeletal System in Female Mice

November 21, 2018
No Seminar – Thanksgiving

November 28, 2018
Michael Borrelli, Ph.D., Professor, Radiology and Neurology, UAMS
Targeted Delivery of Drugs and other Therapeutics

December 5, 2018
Swapnil Sonkusare, Ph.D., Assistant Professor, Molecular Physiology and Biological Physics, University of Virginia, School of Medicine
Peroxynitrite-Induced Impairment of Endothelial Calcium Signaling Networks in Obesity

December 12, 2018
Brett Mitchell, Ph.D., F.A.H.A., Associate Professor, Department of Medical Physiology, Texas A&M Health Science Center, College of Medicine
Effects of Renal Lymphatics on Hypertension

December 19, 2018
No Seminar – Christmas

December 26, 2018
No Seminar – Winter Break

January 2, 2019
No Seminar – Winter Break

January 9, 2019
No Seminar

January 16, 2019
No Seminar

January 23, 2019
No Seminar

January 30, 2019
No Seminar

February 6, 2019
Robert J. Shmookler Reis, D.Phil., Professor, Department of Geriatrics, UAMS. “When Good Proteins Turn Bad…Aggregation Underlies Alzheimer’s Disease and other Age-progressive Pathologies.”

February 13, 2019
To Be Announced

February 20, 2019
Jeffrey Padberg, Ph.D., Associate Professor, Department of Biology, University of Central Arkansas. “Neuroanatomical Organization of the Thalamus and Early Retinofugal Pathways in the Nine Banded Armadillo (Dasypus novemcinctus)”

February 27, 2019
Udai Pandey, Ph.D., Associate Professor, Department of Pediatrics, Human Genetics & Neurobiology, Children’s Hospital of Pittsburgh, University of Pittsburgh Medical Center
Function and Dysfunction of RNA-Binding Proteins in Motor Neuron Degeneration

March 6, 2019
Matthew Johnson, Ph.D., Associate Professor, Behavioral Pharmacology Research Unit, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine. “Psychedelic (5-HT2AR) Psilocybin as a Smoking Cessation Medication”

March 13, 2019
W. Brooks Gentry, M.D., CMO, InterveXion Therapeutics; Professor, Dept of Anesthesiology and Pharmacology and Toxicology, UAMS
“Substance Abuse Therapies: Endpoints for Advanced Phase Clinical Trials”

March 20, 2019
No Seminar – Spring Break

March 27, 2019
Ronald Crystal, M.D., Chairman, Department of Genetic Medicine, Weill Medical College of Cornell University.
“Active and Passive Anti-addiction Vaccines Based on Viral Vector Platforms”

April 3, 2019
Rupak Pathak, Ph.D., Assistant Professor, Division of Radiation Health, Department of Pharmaceutical Sciences, UAMS
“KLF2: A Novel Target to Mitigate Radiation Toxicity”

April 10, 2019
No Seminar – EB Conference

April 17, 2019
Mitchell McGill, Ph.D., Environmental and Occupational Health, UAMS College of Public Health
“The Phosphatidic Acid Switch in Acetaminophen Hepatotoxicity ”

April 24, 2019
Luis Juncos, M.D., Chief of Nephrology, Central Arkansas Veterans Health Care System, and Professor, UAMS Dept of Internal Medicine
“Modulation of Renal Injury via Differential Interplay between the Angiotensin II and Heme Oxygenase Systems”

May 1, 2019
Ricky Yuet-Kin Leung, Ph.D., Associate Professor, Division of Environmental Genetics and Molecular Toxicology, Department of Environmental Health, University of Cincinnati College of Medicine
“Dysregulated Estrogen Signaling in Prostate Cancer”

June 12, 2019
Yu-chieh (Jack) Wang, Ph.D., Assistant Professor, Department of Pharmaceutical Sciences, University of North Texas Health Science Center
“NGLY1-Mediated Protein Deglycosylation: An Emerging Vulnerable Point in Melanoma and Neurodevelopment” 

2019-2020 Seminar Series

Seminars are held on Wednesdays at 3:30 p.m.in Rayford Auditorium (Biomed II, Room 106-2).

October 9, 2019
No Seminar –  Career Day

October 16, 2019
Melissa Clemens, MPH (Graduate Student, UAMS)
Phosphatidic Acid: New Treatment for Liver Injury?

October 23, 2019
Christian Cabanlong,
“Do Synthetic Cannabinoids Exhibit Specific Toxicity Profiles?”

October 30, 2019
Amal Shoeib, M.S.
“Ewing Sarcoma TC-71 Cells Express a Non-CB1/CB2 Cannabinoid Receptor: Potential Novel Therapeutic Target?”

November 6, 2019
James Cardelli, Ph.D., Founder  & President,
Segue Family of Companies,
“Entrepreneurial Adventures Beyond Academics”

November 13, 2019
Syed Imam, Ph.D., Staff Fellow,
Division of Neurotoxicology, National Center for Toxicological Research/FDA,
“Neurotoxicity, Neurotherapeutics, Biomarkers and More.”

November 20, 2019
Shai Siberberg, Ph.D,
Director of Research Quality
NIH National Institute of Neurological Disorders and Stroke (NINDS)
“Assuring a Bright Future for Biomedical Research.”

November 27, 2019
No Seminar – Thanksgiving Break

December 4, 2019
David Henry, M.P.H
“When Healing Harms: Beta Blockers and Cerebral Collateral Arteries.”

December 11, 2019
Joel Vazquez, B.S.
“Discovery of Biomarkers to Differenti-ate Between Liver Injury and Benign Aminotransferase Elevations.”

December 18, 2019
No Seminar – Winter Break

December 25, 2019
No Seminar – Christmas Break

January 1, 2020
No Seminar – Winter Break

January 8, 2020
David Busija, M.D., Ph.D.,
Regents Endowed Professor and Chairman,
Tulane University,
“Mitochondrial Dynamics in the CerebralVasculature During Health and Disease.”

January 15, 2020
Jerry Darsey, Ph.D.,
Director, Center for Molecular Design and Development,
Department of Chemistry, University of Arkansas at Little Rock,
“Modeling Computational Studies of Modified Drug Molecules Binding to Proteins in the Treatment of Parkinson’s Disease.”

January 29, 2020
Lisa K. Brents, Ph.D.,
Assistant Professor, Department of Pharmacology & Toxicology,
University of Arkansas for Medical Sciences,
“The Role of Norbuprenorphine in Buprenorphine-associated Neonatal Opioid Withdrawal Syndrome.”

February 12, 2020
William B. Mattes, Ph.D., DABT,
Director, Division of Systems Biology
U.S. Food and Drug Administration
National Center for Toxicology Research
“Overview of the FDA and Regulatory Aspects of Pharmaceutical Development.”

February 19, 2020
Jessica J. Hawes, Ph.D.,
Acting Deputy Director
Division of Systems Biology
National Center for Toxicological Research
U.S. Food and Drug Administration
“Nonclinical Studies to Support Clinical Trials.”